Our startups
Our diverse collection of innovative ventures tackle pressing challenges across a variety sectors.
From groundbreaking solutions for hearing impairment to technologies enhancing food sustainability, our portfolio showcases how our startups are revolutionising industries, driving positive change, and shaping the future of innovation.
Psychae Therapeutics
Psychae Therapeutics is developing pharmaceutical-grade botanically derived medicines and accompanying psychological treatment tools for major mental health conditions including trauma, mood disorders and addiction.
Therapeutics Sector
Professor Jerome Sarris
Associate Professor Daniel Perkins
Cell Bauhaus
Creating new "in silico” biology and simulation approaches allows Cell Bauhaus to explore and design cellular behaviour, reducing reliance on costly and time consuming trials in the lab. Cell Bauhaus enables computer aided design for biology.
This approach will accelerate innovation in biotechnology and synthetic biology, transform research and development in the new bio-economy, and help tackle some of the world's most urgent challenges.
Software Sector
Dr Megan Cooper
Professor Michael Stumpf
The Leaf Protein Co
In response to the declining biodiversity crucial to maintaining our food systems, The Leaf Protein Co has developed platform technology to extract Earth's most abundant and biodiverse source of protein found in edible leaves.
This helps manufacturers make better plant-based foods with more sustainable ingredients that are better for both human and planetary health.
Agtech Sector
Fern Ho
Connor Balfany
Remagine Labs
With the potential to drastically improve medication adherence, Remagine Labs is changing the treatment of chronic conditions.
Their Transdermal Patch has already gained support and interest with key personal within the field of Epilepsy, proving its potential to improve the daily life of millions of people worldwide.
Medical Devices Sector
Professor Stan Skafidas
Pat Kelly
